Paydirt
KG
Insider

Kathleen P. Gallagher

Chief Program Officer

Kathleen P. Gallagher (Chief Program Officer) filed 6 Form 4 reports in the past 24 months (0 purchases, 6 sales), most often in RNA. The largest single filing was $191K of RNA (5,875 sh × $32.48, as filed), executed Jun 2 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.1M
shares × price, as filed
Last traded
Jun 2 2025
Filed Jun 4 2025
Open performance
Volume by month
$191K$95K$0Oct 2024Apr 2025Oct 2025Apr 2026Jan 2025 · sells $170KFeb 2025 · sells $189KMar 2025 · sells $173KApr 2025 · sells $154KMay 2025 · sells $190KJun 2025 · sells $191K
Buys $0 Sells $1.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 6 filings

Sector per market data · by filing · past 24 months

Most traded names
RNA RNA RNA · 0 buys · 6 sells 6 filings
Recent filings
RNASALE Avidity Biosciences, Inc. View filing → $191K
5,875 sh × $32.48
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $190K
5,875 sh × $32.40
Exec May 1 2025
Filed May 2 2025 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $154K
5,546 sh × $27.83
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $173K
5,875 sh × $29.41
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $189K
5,875 sh × $32.16
Exec Feb 3 2025
Filed Feb 5 2025 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $170K
5,629 sh × $30.16
Exec Jan 22 2025
Filed Jan 23 2025 · 5:30 PM ET